BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6379265)

  • 1. [Comparative study of the effectiveness of korinfar, izoptin and obzidan in patients with variant stenocardia combined with effort stenocardia].
    Shevchenko OP; Peres Peres A; Borisova GA; Sidorenko BA
    Kardiologiia; 1984 Jun; 24(6):64-9. PubMed ID: 6379265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the physical load tolerance of stenocardia patients taking obzidan, korinfar and izoptin separately and together].
    Katsenovich RA; Kostko SZ; Arifdzhanova UA; Khashimov KhA; Vakhidova MA
    Kardiologiia; 1984 Jun; 24(6):69-73. PubMed ID: 6379266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patients with exercise-induced angina pectoris with korinfar and isoptin].
    Peres AP; Sidorenko BA; Shevchenko OP
    Kardiologiia; 1984 Jul; 24(7):77-81. PubMed ID: 6384617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational approach to the medical therapy of angina pectoris: the role of calcium antagonists.
    Maseri A; Parodi O; Fox KM
    Prog Cardiovasc Dis; 1983; 25(4):269-78. PubMed ID: 6336848
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative evaluation of the antianginal efficacy of aldizem and korinfar in patients with stable stenocardia].
    Chumburidze VB; Zubiashvili TG; Gogicheva MI; Berulava II
    Ter Arkh; 1991; 63(8):50-2. PubMed ID: 1792618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
    Picca M; Azzollini F; Cereda A; Pelosi G
    Eur J Clin Pharmacol; 1989; 37(4):325-31. PubMed ID: 2513206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value and limitations of provocative testing to assess the efficacy of treatment in variant angina.
    Waters DD
    Cardiovasc Clin; 1983; 14(1):87-98. PubMed ID: 6352031
    [No Abstract]   [Full Text] [Related]  

  • 8. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exercise-induced attacks of variant angina pectoris].
    Shevchenko OP; Sidorenko BA; Mazaev VP; Batyrbekova LM; Nazarenko VA
    Kardiologiia; 1983 Jun; 23(6):41-4. PubMed ID: 6887681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina.
    Kishida H; Otsu F; Kusama Y; Takayama M; Hayakawa H; Kimura E
    Jpn Heart J; 1982 Nov; 23(6):871-81. PubMed ID: 7161875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiospastic angina pectoris].
    Sidorenko BA; Shevchenko OP
    Kardiologiia; 1983 Jun; 23(6):5-13. PubMed ID: 6411959
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oral calcium-antagonists in spontaneous angina. Verapamil and nifedipine in a double-blind cross-over trial.
    Piccolo E; Cazzin R; Sartori F; Artusi L; Pascotto P
    G Ital Cardiol; 1982; 12(5):359-64. PubMed ID: 6759285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal's variant angina.
    Winniford MD; Johnson SM; Mauritson DR; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):684-8. PubMed ID: 6338688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina.
    Kostuk WJ; Pflugfelder P
    Circulation; 1987 Jun; 75(6 Pt 2):V114-21. PubMed ID: 2882870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.
    Johnston DL; Lesoway R; Humen DP; Kostuk WJ
    Am J Cardiol; 1985 Mar; 55(6):680-7. PubMed ID: 3883739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD; Bogatyrev IV; Uchaĭkina LV; Syrkin AL
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-anginal effect of long-term use of obsidan, corinfar and finoptin in patients with stable exercise-induced stenocardia].
    Furkalo NK; Voronkov LG; Sokolov NF; Lysenko AF
    Klin Med (Mosk); 1991 Jan; 69(1):63-6. PubMed ID: 2023398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the results of the bicycle ergometry test in patients with stress stenocardia after treatment with propranolol and nifedipine].
    Abasova LI; Gel'fgat EB
    Kardiologiia; 1986 Dec; 26(12):51-5. PubMed ID: 3560612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study.
    Winniford MD; Fulton KL; Corbett JR; Croft CH; Hillis LD
    Am J Cardiol; 1985 Feb; 55(4):281-5. PubMed ID: 3969862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.